Do the current guidelines for asthma pharmacotherapy encourage over-treatment?-Reference-Cited by-同舟云学术

Do the current guidelines for asthma pharmacotherapy encourage over-treatment?

Published:2020-05-13 Issue:11 Volume:21 Page:1283-1286
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Bagnasco Diego¹^ORCID,Brussino Luisa²,Caruso Cristiano³,Paoletti Giovanni⁴⁵,Heffler Enrico⁴⁵,Guida Giuseppe⁶,Calzolari Elisa¹,Nicola Stefania²,De Ferrari Laura¹,Passalacqua Giovanni¹^ORCID,Canonica Giorgio Walter⁴⁵^ORCID

Affiliation:

1. Allergy and Respiratory Diseases, IRCCS Policlinico San Martino, University of Genoa, Genoa, Italy

2. Mauriziano Hospital, Department of Medical Science, University of Turin, Turin, Italy

3. Allergy Unit, Fondazione Policlinico A. Gemelli, IRCSS, Rome, Italy

4. Personalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy

5. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy

6. Allergy and Pneumology Unit, A.O. S.Croce E Carle, Cuneo, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1759551

Reference16 articles.

1. Global strategy for asthma management and prevention [Internet]. [cited 2020 Apr 14]. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf.

2. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations

3. As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

4. It is time to change the way we manage mild asthma: an update in GINA 2019

5. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy;Journal of Personalized Medicine;2022-07-20

2. Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center;Biomedicines;2022-01-18

3. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life;World Allergy Organization Journal;2021-02